Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.
Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check6 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check42 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check56 days agoChange DetectedNo new additions were noted, but a significant section of content related to downloading data formats and selecting study fields has been removed.SummaryDifference14%
- Check70 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in CSV, JSON, RIS, and FHIR formats, along with a comprehensive selection of data fields for studies.SummaryDifference16%
- Check78 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.